![]() Pharvaris Pharvaris is a clinical-stage company focused on the discovery and development of oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. | ||
Founding Date | Founding Date 1971 | Founding Date 2015 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Ledbury, GB HQ | Locations Zug, CH HQ Leiden, NL Lexington, US |
Employees | Employees 1041% increase | Employees 108 |

Pharvaris is a clinical-stage company focused on the discovery and development of oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
View company